The rollout of mobile ECG devices by the Academic Health Science Network programme was established to test if an intervention in the health care market place (mobile-ECG devices) could stimulate innovation and improve modifiable health risks at scale; and reduce demand on secondary care.

The evaluation of the roll out of mobile ECG devices was commissioned by the Innovation Agency (North West Coast AHSN hosted by Lancashire Care NHS Foundation Trust), on behalf of the AHSN Network. Wessex AHSN evaluation team were selected through invitation to tender to provide an independent evaluation of how well the programme had met its overarching evaluation question:

“Can a system-wide procurement initiative improve the uptake of innovative technology (mobile ECG) and stimulate the market in primary and community settings, to better identify AF?”